- Home
- GECC vs ALEC Comparison
GECC vs ALEC Comparison
Compare GECC & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GECC
- ALEC
- Stock Information
- Founded
- GECC 2016
- ALEC 2013
- Country
- GECC United States
- ALEC United States
- Employees
- GECC N/A
- ALEC N/A
- Industry
- GECC Finance: Consumer Services
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GECC Finance
- ALEC Health Care
- Exchange
- GECC Nasdaq
- ALEC Nasdaq
- Market Cap
- GECC 123.1M
- ALEC 124.0M
- IPO Year
- GECC N/A
- ALEC 2019
- Fundamental
- Price
- GECC $11.00
- ALEC $1.61
- Analyst Decision
- GECC
- ALEC Buy
- Analyst Count
- GECC 0
- ALEC 8
- Target Price
- GECC N/A
- ALEC $4.50
- AVG Volume (30 Days)
- GECC 27.6K
- ALEC 409.3K
- Earning Date
- GECC 08-04-2025
- ALEC 08-11-2025
- Dividend Yield
- GECC 13.91%
- ALEC N/A
- EPS Growth
- GECC N/A
- ALEC N/A
- EPS
- GECC 0.42
- ALEC N/A
- Revenue
- GECC $42,909,000.00
- ALEC $88,339,000.00
- Revenue This Year
- GECC $32.09
- ALEC N/A
- Revenue Next Year
- GECC $0.51
- ALEC $319.82
- P/E Ratio
- GECC $26.03
- ALEC N/A
- Revenue Growth
- GECC 18.13
- ALEC N/A
- 52 Week Low
- GECC $8.87
- ALEC $0.87
- 52 Week High
- GECC $11.39
- ALEC $6.61
- Technical
- Relative Strength Index (RSI)
- GECC 57.62
- ALEC 50.41
- Support Level
- GECC $10.94
- ALEC $1.74
- Resistance Level
- GECC $11.03
- ALEC $2.00
- Average True Range (ATR)
- GECC 0.09
- ALEC 0.12
- MACD
- GECC -0.01
- ALEC 0.00
- Stochastic Oscillator
- GECC 90.91
- ALEC 17.06
About GECC Great Elm Capital Corp.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generate both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.